Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04313140

Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
500 (estimated)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Glioma is a tumor of the central nervous system. These lesions are sorted with the WHO ranking regarding the tumoral oncotype. The tumoral MRI assessment is the first step before any medical decision. Currently, only anatomical biopsy can give the tumor grade definition and help to define the most adapted treatment.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDiagnostic testThe intervention occurs only one time (for 2h30), the MRI examination is divided as follow: * Cinicial MRI (50 minutes) * Research MRI (Phosphorus Spectroscopy, Sodium Imaging)

Timeline

Start date
2021-02-22
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2020-03-18
Last updated
2023-02-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04313140. Inclusion in this directory is not an endorsement.

Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging (NCT04313140) · Clinical Trials Directory